Evidence map›Paper›PMID 39461278›Full record

ReviewDNA repair2024

APE1 is a master regulator of the ATR-/ATM-mediated DNA damage response.

Haichao Zhao, Christine Richardson, Ian Marriott, In Hong Yang, Shan Yan

Abstract readReview
In one paragraph

Review in DNA repair, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. ALK Knock-In Reporter Reveals APE1 as a Negative Regulator ofInternational journal of molecular sciences · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haichao ZhaoDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Christine RichardsonDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; School of Data Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Ian MarriottDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
In Hong YangCenter for Biomedical Engineering and Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; Department of Mechanical Engineering and Engineering Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Shan YanDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; School of Data Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA. Electronic address: shan.yan@charlotte.edu.

Funding

Mechanism of APE1 in DNA damage responseR01CA225637 · NCI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YAN, SHAN · 2018 to 2022
$1.9M
Substance P exacerbation of staphylococcal bone damageR01AI170012 · NIAID · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI Morgan Brittany Johnson, Ian Marriott · 2022 to 2026
$1.9M
Embryonic Stem Cell Properties in CancerR01CA128571 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MERRILL, BRADLEY J · 2008 to 2012
$1.8M
Bridges Fellow Program: Promoting Undergraduate Success in Biomedical SciencesR25GM128571 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI EDWARD, CHELSEA, GRIMSLEY, CLIFFORD · 2018 to 2022
$865k
Neuroprotection for chemotherapy induced peripheral neuropathyR15CA290570 · NCI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YANG, IN HONG · 2024 to 2024
$462k
ATM activation by DNA single-strand breaksR21ES032966 · NIEHS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YAN, SHAN · 2021 to 2022
$415k
Mechanism of APE2 in genome integrityR03CA270663 · NCI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YAN, SHAN · 2023 to 2024
$149k
NCI NIH HHS R01 CA128571NCI NIH HHS R01 CA225637NCI NIH HHS R03 CA270663NCI NIH HHS R15 CA290570NIAID NIH HHS R01 AI170012NIEHS NIH HHS R21 ES032966NIGMS NIH HHS R25 GM128571
6 · The paper itself

Abstract

To maintain genomic integrity, cells have evolved several conserved DNA damage response (DDR) pathways in response to DNA damage and stress conditions. Apurinic/apyrimidinic endonuclease 1 (APE1) exhibits AP endonuclease, 3'-5' exonuclease, 3'-phosphodiesterase, and 3'-exoribonuclease activities and plays critical roles in the DNA repair and redox regulation of transcription. However, it remains unclear whether and how APE1 is involved in DDR pathways. In this perspective, we first updated our knowledge of APE1's functional domains and its nuclease activities and their specific associated substrates. We then summarized the newly discovered roles and mechanisms of action of APE1 in the global and nucleolar ATR-mediated DDR pathway. While the ATM-mediated DDR is well known to be activated by DNA double-strand breaks and oxidative stress, here we provided new perspectives as to how ATM DDR signaling is activated by indirect single-strand breaks (SSBs) resulting from genotoxic stress and defined SSB structures, and discuss how ATM kinase is directly activated and regulated by its activator, APE1. Together, accumulating body of new evidence supports the notion that APE1 is a master regulator protein of the ATR- and ATM-mediated DDR pathways. These new findings of APE1 in DDR signaling provide previously uncharacterized but critical functions and regulations of APE1 in genome integrity.

Indexed as

Ataxia Telangiectasia Mutated ProteinsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA RepairAnimalsHumansSignal TransductionAPEX1 protein, humanAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanDNA-(Apurinic or Apyrimidinic Site) LyaseAPE1ATMATRDNA damage responseDNA repair

Identifiers

PMID39461278
PMCPMC11611674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.